Cargando…
Stereotactic body radiation therapy (SBRT) following Yttrium-90 ((90)Y) selective internal radiation therapy (SIRT): a feasibility planning study using (90)Y delivered dose
Objective. (90)Y selective internal radiation therapy (SIRT) treatment of hepatocellular carcinoma (HCC) can potentially underdose lesions, as identified on post-therapy PET/CT imaging. This study introduces a methodology and explores the feasibility for selectively treating SIRT-underdosed HCC lesi...
Autores principales: | Mee, Stephen F, Polan, Daniel F, Dewaraja, Yuni K, Cuneo, Kyle C, Gemmete, Joseph J, Evans, Joseph R, Lawrence, Theodore S, Dow, Janell S, Mikell, Justin K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOP Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001703/ https://www.ncbi.nlm.nih.gov/pubmed/36780696 http://dx.doi.org/10.1088/1361-6560/acbbb5 |
Ejemplares similares
-
Y-90 SIRT: evaluation of TCP variation across dosimetric models
por: Van, Benjamin J., et al.
Publicado: (2021) -
Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis
por: Liu, Jason, et al.
Publicado: (2021) -
Stereotactic Inverse Dose Planning After Yttrium-90 Selective Internal Radiation Therapy in Hepatocellular Cancer
por: Abbott, Elliot, et al.
Publicado: (2020) -
Yttrium 90 Therapy: Is the Future Surgical?
por: Garlipp, Benjamin
Publicado: (2020) -
Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors
por: Kucuk, Ozlem N, et al.
Publicado: (2011)